# Intuitive Surgical Narrows 2026 da Vinci Procedure Growth Outlook By John Kim Canonical URL: https://www.tokenpost.com/news/business/36628 Published: 2026-10-21T11:53:42.000Z Updated: 2026-10-21T11:53:42.000Z Section: Business > Pricing changes and a China policy shift are expected to reduce instruments-and-accessories revenue per da Vinci procedure by 3%-5% after full implementation. Intuitive Surgical narrowed its forecast for worldwide da Vinci procedure growth in 2026 to 14%-15% and outlined pricing changes expected to reduce instruments-and-accessories revenue per procedure. The previous growth range was 13.5%-15.5%. Intuitive expects full-year procedure growth near the midpoint of the revised range. The company estimates that its planned pricing changes, together with a policy-driven price reduction in China, will lower instruments-and-accessories revenue per da Vinci procedure by 3%-5% once fully implemented. That estimate assumes the mix of procedures, products and geographic markets stays the same. It concerns revenue per procedure, while the 14%-15% forecast concerns the number of procedures performed. Worldwide da Vinci procedures increased 14% in the third quarter. Growth was 10% in the U.S. and 20% outside the U.S. Intuitive’s [third-quarter financial results]() showed revenue rising 22% to $3.05 billion. Intuitive plans to extend the useful lives of some EndoWrist instruments and introduce volume-based pricing for high-volume benign procedures. The China price reduction is expected to begin in November 2026. The extended-life instruments are planned for a country-by-country rollout beginning in the first half of 2027. In the U.S., those instruments still require 510(k) regulatory clearance. ## Links in this article - [third-quarter financial results](https://www.tokenpost.com/news/business/36498)